Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 25, 2022

View Archived Issues

Redox-tuned [18F]4FN radiopharmaceutical is useful for imaging innate immunity activation

Evaluating effect of LyeTxI-b on colorectal cancer using chicken chorioallantoic membrane model

Bayer and collaborators patent CSNK1 inhibitors

Foghorn Therapeutics divulges new PROTACs

Jazz Pharmaceuticals synthesizes new Raf kinase inhibitors

Beijing Jacobio Pharmaceuticals presents new glutaminase inhibitors

Chinese investigators identify new PI3Kdelta inhibitors

Osteocytic Cx43 hemichannels as new therapeutic target for treating bone loss and osteoporosis

GI Innovation and CellKey sign biomarker joint research MoU

LABP-66 shows promise for the treatment of multiple sclerosis

VK-1727 reduces EBV proliferation in cells from patients with multiple sclerosis

Lung microbiome affects brain immune cells

Targeting HNRNPA1 effective for treating multiple sclerosis-associated neurodegeneration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026